Skip to main content

Advertisement

Table 1 Characteristics of 74 NSCLC patients with postoperative locoregional recurrence treated with radical radiotherapy

From: Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy

Characteristic Number of patients (%)
Sex
 Male 54 (73.0)
 Female 20 (27.0)
Stage of primary tumora
 I 17 (23.0)
 II 16 (21.6)
 III 34 (45.9)
 Unknown 7 (9.5)
Histology
 Squamous cell carcinoma 18 (24.3)
 Adenocarcinoma 41 (55.4)
 Lymphoepithelioma-like carcinoma 10 (13.3)
 Others 5 (6.8)
EGFR status
 Mutation 14 (18.9)
 Wild-type 37 (50.0)
 Unknown 23 (31.1)
Recurrence site
 Stump 8 (10.8)
 Regional lymph nodes 56 (75.7)
 Ipsilateral lung 6 (8.1)
 Both stump and regional lymph nodes 3 (4.0)
 Both regional lymph nodes and ipsilateral lung 1 (1.4)
Concurrent chemotherapy
 Yes 59 (79.7)
 No 15 (20.3)
Radiation technique
 3D-CRT 5 (6.8)
 IMRT 62 (83.8)
 SBRT 7 (9.4)
  1. NSCLC non-small cell lung cancer, EGFR epidermal growth factor receptor, 3D-CRT 3-dimensional conformal radiotherapy, IMRT intensity-modulated radiotherapy, SBRT stereotactic body radiotherapy
  2. aThe 7th edition of the American Joint Committee on Cancer (AJCC) staging system was used